Surgical device maker Misonix Inc. (NSDQ: MSON) inked a three-year exclusive distribution agreement with Bangkok, Thailand-based JPL Medical for its BoneScalpel ultrasonic bone cutter.
The BoneScalpel is an alternative to rotary bone cutters and allows doctors to make precise cuts through bone and hard tissue while largely preserving soft tissue.
"Misonix is very pleased to add JPL to our expanding distribution network in Asia. Their reputation as a quality, specialty distributor of advanced medical products has been well established," Michael McManus Jr., Misonix’s president & CEO, said in prepared remarks. "Their commitment to neurosurgery and spine surgery matches Misonix’s own focus on these key market segments."
Earlier this week, the surgical device makers expanded their Asian market further by inking a four-year exclusive distribution agreement with New Delhi, India-based Cure Surgicals.
The agreement gives Cure Surgicals the right to sell the Misonix BoneScalpel and its SonaStar surgical aspirator throughout India.
Hospital GPOs have been vocal about signing contract recently, perhaps in response to Medtronic’s (NYSE:MDT) headline-making, Wall Street-pleasing decision to cut several contracts worth an estimated $2 billion a year for its cardiovascular and orthopedic products with Novation in February.